Our findings outline the role of miR-122 restoration in the induction of apoptosis of HCC cells with different genomic contexts as well as TP53 mutational status, indicating the high potential of a miR-122-based strategy that might counteract the high heterogeneity of human HCC, which represents a major challenge in terms of treatment effectiveness. Here, TP53 is linked to hepatocellular carcinoma.